Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood

Journal article

R. Hanna AL-Shaikh, K.R. Jansen-West, L. Petrucelli, Z.K. Wszolek and M. Prudencio

Movement Disorders, Vol.37(5), pp.1120-1121

2022

PMID: 35587620

Abstract

Ataxin-3

Humans

Machado-Joseph Disease

Nuclear Proteins

Peptides

ataxin 3

biological marker

polyglutamine

protein antibody

recombinant protein

ataxin 3

nuclear protein

peptide

polyglutamine

clinical feature

human

immunoassay

Letter

limit of detection

limit of quantitation

onset age

protein blood level

protein cerebrospinal fluid level

protein urine level

spinocerebellar ataxia type 3

spinocerebellar degeneration

genetics

Machado Joseph disease

url

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130348049&doi=10.1002%2fmds.29008&partnerID=40&md5=99e8d67cb15264da3b47916aafee5900View

1 Record Views

Title: Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
Creators: R. Hanna AL-Shaikh
K.R. Jansen-West - Mayo Clinic in Florida
L. Petrucelli - Mayo Clinic in Florida
Z.K. Wszolek
M. Prudencio - Jacksonville College
Publication Details: Movement Disorders, Vol.37(5), pp.1120-1121
Publisher: John Wiley and Sons Inc; HOBOKEN
Number of pages: 2
Comment: Export Date: 27 February 2026; Cited By: 0; CODEN: MOVDE
Academic Unit: Level 02 - Executives; Executives; UMMG Department of Neurology
Resource Type: Journal article
PMID: 35587620
Record Identifier: 991032996192602976